Autolus Therapeutics Plc Asset Turnover Ratio (AUTL), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Autolus Therapeutics Plc  (NASDAQ: AUTL)
 

Autolus Therapeutics Plc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Autolus Therapeutics Plc asset turnover ratio, the ability of Autolus Therapeutics Plc's assets to generate revenue in the second quarter 2026, increased sequentially to 0.21 in the second quarter (Jun 30 2026), yet the ratio remained below the average, as AUTL's position remain challenging.

Within sector 55 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2026 compared to the preceding quarter from 2487 to 3240.

Asset Turnover Ratio Definition



AUTL Asset Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Asset Change -31.59 % -29.38 % -33.28 % -13.4 % -10.35 %
Y / Y Revenue Change 118.37 % 191.89 % 83655.17 % - -
Asset Turnover Ratio (TTM) 0.21 0.15 0.11 0.07 0.04
AUTL's Total Ranking # 3240 # 2487 # 2802 # 3172 # 0
Seq. Asset Change -6.42 % -10.22 % -11.31 % -8.19 % -3.4 %
Seq. Revenue Change 74.27 % 7.94 % 14.6 % 1.3 % 132.94 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 56
Healthcare Sector # 484
Overall Market # 3240

Asset Turnover Ratio Statistics
High Average Low
3.04 1.75 0.43
(Jun 30 2026)   (Dec 31 2022)







Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Anika Therapeutics Inc   0.65 $ 121.370  Millions$ 185.642  Millions
Agenus Inc  0.65 $ 132.693  Millions$ 204.959  Millions
Gyre Therapeutics Inc   0.64 $ 119.383  Millions$ 185.104  Millions
Logicmark Inc  0.64 $ 12.544  Millions$ 19.555  Millions
Strata Critical Medical Inc   0.64 $ 211.642  Millions$ 330.217  Millions
Castle Biosciences Inc   0.64 $ 357.278  Millions$ 562.581  Millions
Vericel Corporation  0.63 $ 306.303  Millions$ 482.434  Millions
Bridgebio Pharma Inc   0.63 $ 713.069  Millions$ 1,130.639  Millions
Ss Innovations International Inc  0.63 $ 52.199  Millions$ 82.833  Millions
Zoetis Inc   0.63 $ 9,517.000  Millions$ 15,214.250  Millions
Rigel Pharmaceuticals Inc  0.62 $ 276.785  Millions$ 445.451  Millions
Bioaffinity Technologies Inc   0.62 $ 5.901  Millions$ 9.518  Millions
Macrogenics Inc   0.61 $ 167.674  Millions$ 272.723  Millions
Tg Therapeutics Inc   0.61 $ 799.536  Millions$ 1,314.186  Millions
Heron Therapeutics Inc   0.60 $ 151.507  Millions$ 250.826  Millions
Akebia Therapeutics Inc   0.60 $ 219.060  Millions$ 363.224  Millions
10x Genomics Inc   0.60 $ 616.566  Millions$ 1,028.638  Millions
Sarepta Therapeutics Inc   0.60 $ 1,974.344  Millions$ 3,302.647  Millions
Heartflow Inc   0.60 $ 210.791  Millions$ 353.085  Millions
Pacira Biosciences inc   0.60 $ 746.164  Millions$ 1,253.752  Millions
Conmed Corporation  0.59 $ 1,371.657  Millions$ 2,315.871  Millions
Emergent Biosolutions Inc   0.59 $ 770.200  Millions$ 1,304.200  Millions
Globus Medical Inc   0.59 $ 3,144.934  Millions$ 5,331.554  Millions
Cvrx inc   0.59 $ 60.164  Millions$ 102.033  Millions
Skinhealth Systems Inc   0.59 $ 289.224  Millions$ 490.811  Millions
Solventum Corporation  0.59 $ 8,310.000  Millions$ 14,151.750  Millions
Radnet Inc   0.58 $ 2,268.932  Millions$ 3,883.896  Millions
Capsovision Inc   0.58 $ 12.804  Millions$ 22.085  Millions
Merit Medical Systems Inc  0.58 $ 1,579.403  Millions$ 2,724.956  Millions
Enovis Corp  0.58 $ 2,294.938  Millions$ 3,966.621  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.